Esbly, France

Sylvie Beaudenon


Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 204(Granted Patents)


Location History:

  • Clamart, FR (1995 - 1999)
  • Highland Park, NJ (US) (1999)
  • Esbly, FR (1998 - 2004)

Company Filing History:


Years Active: 1995-2004

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Sylvie Beaudenon: Innovator in Human Papillomavirus Research

Introduction

Sylvie Beaudenon is a notable inventor based in Esbly, France. She has made significant contributions to the field of immunology, particularly in the study of human papillomavirus (HPV). With a total of 8 patents to her name, her work has advanced the understanding and detection of HPV, which is crucial for public health.

Latest Patents

Among her latest patents, Beaudenon has developed immunogenic compositions of human papillomavirus and sera produced therefrom. This includes a purified human papillomavirus gene selected from a group of specific HPV types, such as HPV-2d, HPV-10b, HPV-14a, and others. The polypeptides encoded by these genes can be utilized in immunogenic compositions. Additionally, she has focused on HPV DNA and the probes derived from these papillomaviruses, which are essential for detecting HPV effectively.

Career Highlights

Beaudenon has had a distinguished career, working with prestigious institutions such as Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in the development of methods for HPV detection and the creation of immunogenic compositions that can aid in vaccine development.

Collaborations

Throughout her career, Beaudenon has collaborated with esteemed colleagues, including Gerard Orth and Dina Kremsdorf. These partnerships have enriched her research and contributed to the advancement of HPV studies.

Conclusion

Sylvie Beaudenon stands out as a key figure in the field of HPV research, with her innovative patents and collaborations paving the way for future advancements in immunology. Her work continues to have a lasting impact on public health and the understanding of human papillomavirus.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…